Clinical trials for Meningitis

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Meningitis. For all clinical trials, go to clinical trials search

This list shows clinical trials for Meningitis

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Meningitis
Title Recruitment status Location
Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12 Not recruiting United Kingdom
Can we Reduce the Number of Vaccine Injections for Children? Not recruiting United Kingdom
How well does meropenem treat meningitis in infants below and including 90 days of age Not Recruiting United Kingdom
Meropenem in meningitis in children up to 90 days of age Not Recruiting United Kingdom
Study of Meningococcal B Vaccine and ACWY Conjugate Vaccine in Healthy Adults Not recruiting United Kingdom
B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants Not recruiting United Kingdom
Babies Born Early Antibody Response to Men B Vaccination: BEAR Men B Not recruiting United Kingdom
Understanding the Immune Response to Two Different Meningitis Vaccines Not recruiting United Kingdom
A clinical trial to determine if the investigational MnB vaccine works the same every time a batch (or lot) of the vaccine is made Not Recruiting United Kingdom
Persistence of Antibody Levels and Response to Fifth or Third Meningococcal B Recombinant Vaccine in 4-year Old Healthy Children Who Previously Participated in Study V72P12E1 Not recruiting United Kingdom

Page last reviewed: 12/04/2016

Next review due: 01/04/2019